Latest filing published 04 Nov 2026 for Regeneron Pharmaceuticals, INC., €4.2M.
Filing timeline
BuySaleInsider track record
Joseph J. Larosa: trading record in brief
All filings by Joseph J. Larosa on record concern Regeneron Pharmaceuticals, Inc., in the capacity of board member. Over a trading history stretching from 1 September 2011 to 2 November 2026, the count stands at 146 filings.
No open-market purchase appears, only 84 sales worth €43.1M. The rest of the record consists of 36 share grants and 24 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The newest entry dates from 4 November 2026: an option exercise of €4.2M, in Regeneron Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph J. Larosa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,283 shares@ US$381.92Common StockSEC:0001238303-26-000004:0
- 8,686 shares@ US$950.50Common StockSEC:0001238303-26-000004:1
- 3,939 shares@ US$965.41Common StockSEC:0001238303-26-000004:2
- 527 shares@ US$966.11Common StockSEC:0001238303-26-000004:3
- 12,282 shares@ US$381.920.0054% mcap2.0% of flowCommon StockSEC:0001238303-26-000002:0
- 9,019 shares@ US$830.150.0086% mcap3.2% of flowCommon StockSEC:0001238303-26-000002:1
- 1,396 shares@ US$712.940.5% of flowCommon StockSEC:0001238303-25-000007:1
- 2,476 shares0Common StockSEC:0001238303-25-000007:0
- 12,686 shares@ US$736.774.3% of flowCommon StockSEC:0001238303-25-000005:1
- 14,450 shares@ US$555.6711.1% of flowCommon StockSEC:0001238303-25-000005:0
- 702 shares@ US$730.810.8% of flowCommon StockSEC:0001883850-24-000062:0
- 492 shares@ US$787.000.2% of flowCommon StockSEC:0001968202-24-000135:1
- 2,332 shares0Common StockSEC:0001968202-24-000135:0
- 1,866 shares@ US$1,088.953.0% of flowCommon StockSEC:0001968202-24-000107:0
- 11,084 shares@ US$1,060.135.8% of flowCommon StockSEC:0001883850-24-000036:1
- 14,450 shares@ US$555.6711.9% of flowCommon StockSEC:0001883850-24-000036:0
- 1,608 shares0Common StockSEC:0001883850-24-000032:0
- 1,865 shares@ US$994.902.7% of flowCommon StockSEC:0001968202-24-000096:0
- 1,000 shares@ US$990.001.5% of flowCommon StockSEC:0001968202-24-000080:0
- 1,000 shares@ US$967.651.4% of flowCommon StockSEC:0001968202-24-000073:0
- 1,000 shares@ US$950.001.4% of flowCommon StockSEC:0001968202-24-000058:0
- 24,493 shares@ US$912.3010.8% of flowCommon StockSEC:0001883850-24-000006:1
- 34,000 shares@ US$399.6619.8% of flowCommon StockSEC:0001883850-24-000006:0
- 669 shares@ US$844.090.3% of flowCommon StockSEC:0001968202-23-000052:2
- 2,133 shares0Common StockSEC:0001968202-23-000052:1
25 of 143 declarations
